2024 marks the ninth consecutive year Dominion Diagnostics has received a Worksite Health Award in the Exemplary or Superior Category from BlueCross BlueShield in their Worksite Health Awards!
We are proud to announce that we have been Certified™ by Great Place To Work® in 2024!
90% of our employees affirmed that it’s a great place to work, compared to 57% of employees at a typical U.S. company
2023 marks the eighth consecutive year Dominion Diagnostics has received a Worksite Health Award in the Exemplary or Superior Category from BlueCross BlueShield in their Worksite Health Awards!
Dominion Diagnostics was recently named as one of the 2023 Best Places to Work in Rhode Island. This marks the fourth year in a row, and seventh time overall, that Dominion has been recognized with this award.
Dominion Diagnostics was recently named as one of the 2022 Best Places to Work in Rhode Island. This marks the third year in a row, and sixth time overall, that Dominion has been recognized with this award.
Dominion Diagnostics was recognized with an Exemplary Worksite Health Award from Blue Cross & Blue Shield of Rhode Island (BCBSRI) and the Greater Providence Chamber of Commerce (the Chamber) for effective programs encouraging employee health and well-being in a meaningful way.
Dominion’s Research & Development team recently participated in the international conference for mass spectrometry, American Society for Mass Spectrometry or ASMS. Ana Grenier, Ph.D. was selected to present as one of the speakers where she presented a talk called “Strategies to Identify and Mitigate Interferences in Urine Drug Testing LC MS/MS Methods.”
Dominion Diagnostics is a well-respected, trusted healthcare company with over two decades of experience and expertise delivering patient-centered drug monitoring solutions, improved treatment outcomes and actionable clinical information to inform care.
A new scholarship advancing addiction recovery in the state of Vermont has been established to support the Vermont Foundation of Recovery (VFOR) by Dominion Diagnostics
Today, Rhode Island-based medical laboratory Dominion Diagnostics joined thousands of other organizations and individuals across the globe to commemorate International Overdose Awareness Day during an event held for its employees. The day itself demands urgent action and is aimed to raise awareness of overdose and reduce the stigma of a drug-related death.
Creatinine adjustment is essential for accurate interpretation of drug elimination in many cases. Learn from our clinical services team about how elimination monitoring can help you to better understand your patient’s results.
Lawrence Andrade, UC’94, has to stay sharp to outpace street-drug kingpins. As the head of R&D at Dominion Diagnostics, a clinical toxicology lab and a leading maker of drug tests, Andrade’s job is to detect when people have drugs in their system. Not only does he have to stay on top of industry trends and technology, but he also has to keep an eye on the latest drugs to hit the streets. No small task, given the U.S. opioid epidemic, which has led to an explosion of drug abuse and lent new urgency to accurate drug testing.
Speaker Greg Hughes hosted a conversation on homelessness, substance abuse and mental health with leading experts in the field. The event featured Dominion Diagnostics Scientific Advisory Board Member David E. Smith, MD and Mary P. Hauser, MA, Vice President of Addiction Services and New Market Development for Dominion Diagnostics.
Today, the Institute for the Advancement of Behavioral Healthcare and Dominion Diagnostics announce they will continue their long-standing partnership over the next two years to support education for addiction treatment professionals facing the substance abuse and addiction crisis.
In 2017, Dominion Diagnostics, LLC celebrated two decades as one of the country’s leading drug monitoring companies. Delivering the highest level of commitment to compliance, quality, innovative technology and tools, clinically relevant education and customer support has led them to be a premier choice in laboratory testing for the addiction treatment, behavioral health, and pain management fields.
Dominion Diagnostics has been named as one of the 2017 Best Places to Work in Rhode Island. First recognized two years ago among the 2015 Best Places to Work in Rhode Island winners, this marks Dominion’s second honor in the annual list.
Dr. Kenneth Blum has been included in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dominion Diagnostics will continue as the Title Sponsor of the 2016 National Conference on Addiction Disorders (NCAD).
The rise in opiate abuse and the emergence of synthetic drugs with street names like “n-bomb,” “bath salts,” and spice” have increased the demand for accurate drug testing and monitoring services.
Dominion Diagnostics has been announced by Providence Business News as one of 34 winners in the fourth annual Healthiest Employers of Rhode Island recognition program. The honor was largely based on Dominion’s ACHIEVE Health & Wellness Program.